Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
December 6, 2022
Patent Application Number
16845924
Date Filed
April 10, 2020
Patent Citations
Patent Citations Received
Patent Primary Examiner
Antitumor antagonists that bind specifically to immune checkpoint regulator and/or components of the angiogenesis pathways and/or components of the TGF pathway are disclosed. Also disclosed is a method of treating proliferative disorders with the antitumor antagonists.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
